Navigation Links
Vigene Biosciences Acquires the cGMP Manufacturing Facility and Assets of Omnia Biosciences
Date:11/29/2016

ROCKVILLE, Md., Nov. 29, 2016 /PRNewswire/ -- Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, announced today that the company has entered into a definitive agreement to acquire the assets of Omnia Biologics, Inc. (Omnia), including Omnia's cGMP facility and equipment. The financial terms of the transaction were not disclosed.

The assets acquired by Vigene from Omnia will include a 7,000 square-foot laboratory space, including three cGMP manufacturing suites and one process development laboratory for viral vector production, including AAV, lentivirus and adenovirus. Vigene will also acquire Omnia's cGMP quality system and personnel qualified for manufacturing clinical grade viral vectors.

"We are pleased to have taken this step to expand our cGMP capacity and capability," stated Dr. Zairen Sun, Vigene's CEO. "We believe that the cGMP capability and capacity complement the current strong position of Vigene in the viral vector research reagent market. We plan to take full advantage of our new cGMP facilities by exploring and developing new partnerships with biotech and pharmaceutical companies to further their gene and cell therapy pipeline development."

"Vigene is the perfect company to acquire Omnia," stated Dr. Dale VanderPutten, President and CEO of Omnia. "We feel strongly that this transaction will catapult Vigene into a leading position in cGMP vector production. The fact that Vigene's existing facilities are in close proximity to Omnia's cGMP facility will be conducive to the integration of the Omnia assets and personnel into the Vigene business."

Shulman, Rogers, Gandal, Pordy & Ecker, P.A. served as legal advisor to Vigene in the transaction.

About Vigene Biosciences

Vigene Biosciences, Inc is a leader in viral vector based gene delivery for both life science research, gene therapy and cell therapy purposes. Headquartered in Rockville, Maryland, Vigene offers AAV, lentivirus and adenovirus based products and custom services. Both research grade and cGMP grade AAV, lentiviral and adenoviral vectors are available. Please visit www.vigenebio.com

About Omnia Biologics

Omnia Biologics, Inc offers cGMP production and process development services for gene therapeutics through commercial recombinant proteins. Headquartered in Rockville, Maryland, the company has both non-cGMP and cGMP facilities for process development through Phase I/II manufacture. Please visit www.omniabiologics.com

Contact Information

Jeffrey Hung, Ph.D. 

Chief Commercial Officer

Vigene Biosciences

301-251-6638

jhung@vigenebio.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vigene-biosciences-acquires-the-cgmp-manufacturing-facility-and-assets-of-omnia-biosciences-300368062.html


'/>"/>
SOURCE Vigene Biosciences
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. ACEA Biosciences Appoints Li Xu, M.D. as Chief Medical Officer
2. DuPont Industrial Biosciences and MIAVIT Announce Supply Agreement for Biogas Enzymes
3. Agro BioSciences Expands Probiotic Strain Portfolio
4. ARMO BioSciences Immunotherapy AM0010 Receives Orphan Drug and Fast Track Designations from the U.S. FDA for the Treatment of Pancreatic Cancer
5. DuPont Industrial Biosciences Launches New DuPont™ SYNERXIA® Fermentation System
6. Vortex Biosciences Appoints Dr. Massimo Cristofanilli As Chairman of Newly Formed Scientific Advisory Board
7. Proove Biosciences Appoints John Steiner to Board of Directors
8. The ART BMC System by Celling Biosciences Is Revolutionizing the Practice of Cell Therapy
9. Proove Biosciences Acquires Algynomics, Inc.
10. Proove Biosciences Announces Strategic Partnership with McGill University to Study Link between Pain and Genetics
11. Dr. Nancy Gillett Joins Flagship Biosciences' Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/13/2018)... ... November 13, 2018 , ... , Park Systems, world leader in ... the increasingly growing demand for AFM technology in China, Park Systems has decided to ... an office in Beijing equipped with Park AFM. , The Grand Opening of the ...
(Date:11/9/2018)... , ... November 08, 2018 , ... ... of custom industrial automation and IT solutions with 140 employees on both the ... Fair®, taking place at the Pennsylvania Convention Center on November 14 and 15 ...
(Date:11/5/2018)... ... November 05, 2018 , ... USARAD Holdings ... Siemens Healthineers and several healthcare VC firms announces at Distributed Health 2018 conference ... history by purchasing tokens and obtaining its first radiology interpretations, one of the ...
(Date:10/31/2018)... ... ... Rooam , the premier payment platform for the nightlife and hospitality ... of the Tally payment app, the leading payment platform in Chicago that allows users ... market share and increase the number of restaurant and bar locations offered on its ...
Breaking Biology Technology:
(Date:12/5/2018)... ... December 04, 2018 , ... Urological Associates of Southern ... Center of Excellence. The designation recognizes that Dr. Choi has achieved a high ... to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia ...
(Date:11/29/2018)... ... November 29, 2018 , ... Tosoh Bioscience LLC announced ... acquiring full ownership. The transaction was approved by the Board of Directors of ... “We are extremely pleased to team up with Tosoh Bioscience to offer customers ...
(Date:11/27/2018)... ... November 27, 2018 , ... LabArchives today announced a ... integrate the LabArchives Classroom Edition with Current Protocols Essential Laboratory Techniques for use ... January of 2019. , The integration of LabArchives Classroom Edition and ...
Breaking Biology News(10 mins):